These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26261902)

  • 21. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies in children with type 2 diabetes mellitus.
    Umpaichitra V; Banerji MA; Castells S
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():525-30. PubMed ID: 12017227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL.
    Landgraf W; Owens DR; Frier BM; Zhang M; Bolli GB
    Diabetes Obes Metab; 2020 Mar; 22(3):315-323. PubMed ID: 31608548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J; Seidel D; Schenker M; Ziegler AG
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.
    Hope SV; Knight BA; Shields BM; Hill AV; Choudhary P; Strain WD; McDonald TJ; Jones AG
    Diabetologia; 2018 Jan; 61(1):66-74. PubMed ID: 28983693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
    Bosi E; Boulware DC; Becker DJ; Buckner JH; Geyer S; Gottlieb PA; Henderson C; Kinderman A; Sosenko JM; Steck AK; Bingley PJ;
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2881-2886. PubMed ID: 28531305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
    Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
    Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
    Yu L; Dong F; Miao D; Fouts AR; Wenzlau JM; Steck AK
    Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study.
    Heller SR; Geybels MS; Iqbal A; Liu L; Wagner L; Chow E
    Diabetologia; 2022 Jan; 65(1):55-64. PubMed ID: 34704120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers.
    Lindehammer SR; Hansson I; Midberg B; Ivarsson SA; Lynch KF; Dillner J; Lernmark A;
    J Reprod Immunol; 2011 Jan; 88(1):72-9. PubMed ID: 21111487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.
    Andersson C; Carlsson A; Cilio C; Cedervall E; Ivarsson SA; Jonsdottir B; Jönsson B; Larsson K; Neiderud J; Lernmark A; Elding Larsson H;
    Pediatr Diabetes; 2013 Aug; 14(5):341-9. PubMed ID: 23469940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zinc transporter 8 (ZnT8) autoantibody prevalence in black South African participants with type 1 diabetes.
    Bhola S; Cave EM; Bhana S; Crowther NJ; Padoa CJ
    BMC Endocr Disord; 2021 Jul; 21(1):151. PubMed ID: 34271898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes.
    Sørgjerd EP
    Curr Diabetes Rev; 2019; 15(3):199-204. PubMed ID: 30058495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.
    ; Mellbin LG; Rydén L; Riddle MC; Probstfield J; Rosenstock J; Díaz R; Yusuf S; Gerstein HC
    Eur Heart J; 2013 Oct; 34(40):3137-44. PubMed ID: 23999452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies against ZnT8 are rare in Central-European LADA patients and absent in MODY patients, including those positive for other autoantibodies.
    Heneberg P; Šimčíková D; Čecháková M; Rypáčková B; Kučera P; Anděl M
    J Diabetes Complications; 2019 Jan; 33(1):46-52. PubMed ID: 30377089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.